tradingkey.logo
tradingkey.logo
検索

Phibro Animal Health Corp

PAHC
ウォッチリストに追加
33.140USD
+1.040+3.24%
終値 07/02, 13:00ET15分遅れの株価
1.34B時価総額
14.11直近12ヶ月PER

詳細情報 Phibro Animal Health Corp 企業名

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Phibro Animal Health Corpの企業情報

企業コードPAHC
会社名Phibro Animal Health Corp
上場日Apr 11, 2014
最高経営責任者「CEO」Bendheim (Jack C)
従業員数2475
証券種類Ordinary Share
決算期末Apr 11
本社所在地Glenpointe Centre East, 3Rd Floor
都市TEANECK
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号07666
電話番号12013297300
ウェブサイトhttps://www.pahc.com/
企業コードPAHC
上場日Apr 11, 2014
最高経営責任者「CEO」Bendheim (Jack C)

Phibro Animal Health Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
41.24K
+24.25%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
41.24K
+24.25%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--

よくある質問

Phibro Animal Health Corpの上位5名の株主は誰ですか?

Phibro Animal Health Corpの上位5名の株主は以下のとおりです。Mr. Glenn C. David

Phibro Animal Health Corp(PAHC)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Phibro Animal Health Corpの株式を保有している機関は474社あり、保有株式の総市場価値は約22.03Mで、全体の104.57%を占めています。2025Q4と比較して、機関の持ち株は-645505.00増加しています。

Phibro Animal Health Corpの最大の収益源は何ですか?

2026Q1において、MFAs and Other部門がPhibro Animal Health Corpにとって最大の収益を生み出しており、その金額は202.11Mで、全収益の54.05%を占めています。